EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib - Wikidata - wikimedia - TriplyDB

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

http://www.wikidata.org/entity/Q58727143

about

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

http://www.wikidata.org/entity/Q58727143

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

EPIGIST: An observational real ...... omal tumors receiving imatinib

@en

EPIGIST: An observational real ...... omal tumors receiving imatinib

@nl

type

label

EPIGIST: An observational real ...... omal tumors receiving imatinib

@en

EPIGIST: An observational real ...... omal tumors receiving imatinib

@nl

prefLabel

EPIGIST: An observational real ...... omal tumors receiving imatinib

@en

EPIGIST: An observational real ...... omal tumors receiving imatinib

@nl

P1433

Q58727143-47804332-F991-44A9-B350-7CABBFDF38B6

P1476

Q58727143-DD1CFB82-B9FB-4442-942F-2F74D9B17161

P2093

Q58727143-2B813CFA-7CF2-4CDA-BAD5-F13C28B2F474

Q58727143-301E505D-26D1-4C5A-B240-FC2BA054D0EB

Q58727143-3FC05377-B915-457B-A444-5829124B5B7D

Q58727143-4A6708A0-F537-4201-8891-225DA18531E8

Q58727143-674013DB-2323-4609-951D-251671A37EA2

Q58727143-6B410ACA-38EA-4D8F-AAA5-94DF01270784

Q58727143-6FB58B56-7BDD-452F-8129-01E8728BB54C

Q58727143-7412366D-5A2B-4E35-8AB2-64C65FD8528B

Q58727143-75C51F08-EB81-4634-BF53-E070796C8581

Q58727143-8C8B9354-580E-4DE2-A2AD-1623C932D2C1

P2860

Q58727143-0161A8C7-182E-4A95-9755-2F97889F29D0

Q58727143-01763417-78D0-4FD2-A378-5D13343F98BE

Q58727143-1F404885-87DC-4FD5-A7B6-1C3291E96B43

Q58727143-20C484D4-2FBD-44BD-80A9-7E80412522B0

Q58727143-43542CB3-BDC0-40B7-8EEA-5D331A7204C8

Q58727143-4EC0209F-1CA1-4DE5-AF3D-CD88EBBC8BCD

Q58727143-568FFF72-B514-47B6-AE1B-34489853FB15

Q58727143-643A8D1B-78A7-485B-B321-DFFD8CB2EBC3

Q58727143-750785FF-E694-4836-A753-2D3727A5B918

Q58727143-8A1CCDEB-1003-4B15-9AA8-693212EE3293

P304

Q58727143-22F143A2-7C11-49A9-8B4F-9E43D7BC8244

P31

Q58727143-8EF23168-9C97-4B24-9AC6-FA098FF489A3

P356

Q58727143-897CDFB8-DE69-46C7-AAF9-C789E984A7B9

P407

Q58727143-31212055-3A03-4642-A71B-C871054B0C03

P433

Q58727143-F0D4041C-95AB-41E2-BDDF-3CE239EC6FFA

P478

Q58727143-15EFA08B-8ADB-49B4-A96B-E082F22C8A5C

P50

Q58727143-F77D929B-62DC-49F5-8EBF-07C701D4BFFF

P577

Q58727143-290D83F9-1A69-42C7-84B3-C99645946DBC

P698

Q58727143-D16F1C43-2029-480C-97F0-45A8536D50A8

P932

Q58727143-D6558F1C-AED5-4C1C-A0AA-067DBA92C9F1

P356

JOURNAL.PONE.0204117

P1433

P1476

EPIGIST: An observational real ...... omal tumors receiving imatinib

@en

P2093

Antoine Italiano

http://www.w3.org/2001/XMLSchema#string

Axel Le Cesne

http://www.w3.org/2001/XMLSchema#string

Dominique Arsène

http://www.w3.org/2001/XMLSchema#string

Florence Duffaud

http://www.w3.org/2001/XMLSchema#string

Frank Priou

http://www.w3.org/2001/XMLSchema#string

François Bertucci

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Blay

http://www.w3.org/2001/XMLSchema#string

Loic Chaigneau

http://www.w3.org/2001/XMLSchema#string

Maria Rios

http://www.w3.org/2001/XMLSchema#string

Nicolas Isambert

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies

The MOS 36-ltem Short-Form Health Survey (SF-36)

Gastrointestinal stromal tumor: a clinical overview

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.

Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.

Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients.

Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumors

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.

P304

e0204117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0204117

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Bouché

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30226855

http://www.w3.org/2001/XMLSchema#string

P932

6143255

http://www.w3.org/2001/XMLSchema#string